Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | THRB | P10828 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8636270 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL39514 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL39603 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL27130 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL217238 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL1133315 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL30673 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL1132722 | 1.00 | TSHR (0.67) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL23784490 | 0.96 | TSHR (0.63) | TSHRCYP3A4THRBMEN1HTT | |
| SCHEMBL13335222 | 0.96 | TSHR (0.63) | TSHRCYP3A4THRBMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| US-12095081-B2 | Electrolytic solution and electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2024-09-17 | — | — | US | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240014378-A1 | POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
| CN-116918095-A | Positive electrode and electrochemical device | 株式会社村田制作所 | 2023-10-20 | — | — | CN | disclosed |
| US-20230337452-A1 | PHOSPHORESCENCE-SENSITIZED DELAYED FLUORESCENCE LIGHT EMITTING SYSTEM | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230223525-A1 | ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230183209-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS, INC. (US) | 2023-06-15 | — | — | US | disclosed |
| CN-116250124-A | Electrochemical device | 株式会社村田制作所 | 2023-06-09 | — | — | CN | disclosed |
| EP-4167707-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-2270917-B1 | NON-AQUEOUS ELECTROLYTE FOR SECONDARY CELL AND SECONDARY CELL COMPRISING THE SAME | ASAHI GLASS CO LTD (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-20130101904-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-04-25 | — | — | US | disclosed |
| EP-2579378-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY | Asahi Glass Company, Limited (JP) | 2013-04-10 | — | — | EP | disclosed |
| EP-2495797-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY | Asahi Glass Company, Limited (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120214073-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERIES, AND SECONDARY BATTERY | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2450998-A1 | ELECTROLYTIC SOLUTION FOR CHARGEABLE DEVICE, ELECTROLYTIC SOLUTION FOR LITHIUM ION SECONDARY BATTERY, AND SECONDARY BATTERY | Asahi Glass Company, Limited (JP) | 2012-05-09 | — | — | EP | disclosed |
| US-20120107701-A1 | ELECTROLYTE SOLUTION FOR CHARGEABLE DEVICE, ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY, AND SECONDARY BATTERY | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20110020700-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY CELL, AND SECONDARY CELL | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2270917-A1 | SECONDARY CELL NONAQUEOUS ELECTROLYTE AND SECONDARY CELL | Asahi Glass Company, Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20100168441-A1 | PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183209-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | CRBN, CBL, MDM2 | TSHR 3772/4885CYP3A4 4541/4885THRB 3151/4885 |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | IRAK1, IRAK4, IRAK2 | TSHR 3456/4885CYP3A4 4464/4885THRB 1707/4885 |
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | TSHR 1300/4885CYP3A4 2013/4885THRB 2677/4885 |
| US-20100168441-A1 | PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE | MYB, KCNH2, INTS9 | TSHR 663/4885CYP3A4 204/4885THRB 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.